Navigation Links
Fireflies' glow helps UT Southwestern researchers track cancer drug's effectiveness
Date:5/28/2008

DALLAS May 29, 2008 The gene that allows fireflies to flash is helping researchers track the effectiveness of anti-cancer drugs over time.

UT Southwestern Medical Center researchers are among the first to show that a technique called bioluminescence imaging (BLI) can be used to determine the effectiveness of cancer drugs that choke off a tumors blood supply.

The technique requires a substrate called luciferin to be added to the bloodstream, which carries it to cells throughout the body. When luciferin reaches cells that have been altered to carry the firefly gene, those cells emit light.

Some cancer drugs, however, work by cutting off the blood supply to tumor cells. Given that luciferin is delivered via the vasculature, the researchers set out to determine the kinetics of luciferin delivery and whether BLI techniques could be used to gauge the effectiveness of drugs that destroy blood vessels that feed tumors.

They tested their theory in mice bearing human breast-cancer tumors. Before being introduced to the animals, the tumor cells had been transfected with the firefly gene, which becomes part of the cells as they divide and grow just like genetically modified, herbicide-resistant food crops.

For the study, researchers used BLI to monitor light emissions from tumors following administration of the luciferin. While the mice didnt visibly glow, the researchers used special light-detecting equipment to observe strong correlations between the amount of light emitted and the size of the tumor as it grew. Detected light emission, however, was severely reduced after the vascular-disrupting drug was administered.

What weve done is offer proof-of-concept that BLI may be an effective and cheaper method to assess drug development and effectiveness, said Dr. Ralph Mason, professor of radiology, director of the UT Southwestern Cancer Imaging Center and senior author of the study. The technique is not intended to be used for imaging tumors or diagnosing cancer in humans, but it potentially allows us to do much more efficient pre-clinical experiments.

Dr. Mason stressed that light-emission kinetics depend heavily on tumor location.

The findings are available online and in a future issue of the Journal of the Federation of American Societies for Experimental Biology.

Although magnetic resonance imaging (MRI) remains the gold standard of medical imaging, BLI has its advantages. The noninvasive procedure allows detection of cell viability not accessible by MRI and is less costly, according to researchers at UT Southwestern.

Ultimately, the MRI is much more sophisticated and can do more, but BLI is very straight-forward, Dr. Mason said. Its perfect for evaluating new classes of drugs designed to cause acute vascular changes in tumors because the tests are inexpensive and easy to do.

Dr. Mason said its critically important to develop new chemotherapeutic drugs because existing therapies, when used on their own, are far from ideal. Were lacking the optimal drugs as demonstrated by the people who are not cured by chemotherapy, he said.

He said many existing drugs kill 99 percent of a tumor but allow a few cells to survive, giving the tumor an opportunity to grow back.

Therefore, you need to do a lot of tests to optimize dosing, optimize repeat delivery and probably optimize the co-administration of other, more traditional drugs or therapies, he said. BLI provides an opportunity to do those tests cheaply and efficiently.

Dr. Mason said a handful of faculty members spent several months and about $50,000 to build the BLI instrument they used to collect this data. The team needed the charge-coupled device to detect the light emitted by the cancer cells because the light is too weak for human eyes to see.

Dr. Mason said the device is essentially an astronomy kit.

When youre looking at the stars, youre trying to assess very weak light signals, he said. Were using the same type of instrument to access very weak light coming out of an animal. The difference is that here, we have a very sensitive camera instead of a telescope.


'/>"/>

Contact: Kristen Holland Shear
kristen.hollandshear@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert  

Related medicine news :

1. Monitoring blood flow helps improve prostate biopsies, Jefferson researchers report
2. U.S. Web Site Helps Consumers Compare Hospitals
3. New Anticoagulation Management Software Helps Clinics Enhance Efficiency and Improve Patient Safety
4. Nutritionist to the Stars Helps to Launch European Liquid Appetite Controller
5. Protein Helps ID Thyroid Cancer Nodules
6. Blood Test Helps Docs Assess Breast Cancer Treatment
7. New Supplement Helps Americans Eat Less Every Day
8. New Presidential $1 Coin Helps Highlight National Stroke Awareness Month This May
9. Salient Corporations Performance Management Solution Helps NY State Counties Identify Medicaid Fraud, Waste, and Abuse
10. Web Site Helps Patients Prepare for Hospital Stay
11. Computer Program Helps Drug Abusers Stay Clean
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Fireflies' glow helps UT Southwestern researchers track cancer drug's effectiveness
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... The International ... 7th annual “Imagine Me Beyond What You See” body image mannequin art competition. Selected ... will be showcased and the winner revealed at the 31st annual iaedp Symposium, March ...
(Date:2/24/2017)... ... February 24, 2017 , ... Castle Farms, ... their Military Wedding Giveaway, with the winning couple announced on Feb. 14, 2017, ... generously donated from local vendors: A Matter of Taste, Ryan Rousseau Enterprises, A ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rare Disease Report®, which ... participating in Rare Disease Day events, hosted by the Rare Disease Legislative Advocates ... a website, weekly e-newsletter and quarterly publication, will be conducting interviews with patients ...
(Date:2/23/2017)... ... 23, 2017 , ... EBSCO Information Services (EBSCO) ... for Health and Care Excellence (NICE) framework. The agreement allows purchasers from ... to search, order and purchase medical and healthcare-related content through GOBI ®, ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... today that it will soon begin franchising throughout the U.S. starting this spring. ... help bring the practice of meditation mainstream. Current Meditation will be the first ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... , Australie, le 24 février 2017 ITL Limited, ( ... diversifiée innovante, est ravie d,annoncer les excellents résultats semestriels ... période précédente correspondante. Une présentation complète « Résultats et mise ... consultée ici . Faits marquants ... 2,12 millions $ (Déc. 2015 : 1,04 million $ ; en hausse de 104 %) ...
(Date:2/24/2017)... 23, 2017 Non-alcoholic steatohepataitis (NASH) ... various drugs being developed for the treatment ... drugs that are in various phases of ... focuses on novel pharmacologic drugs & regenerative ... therapies, recombinant proteins and RNA-based therapeutics, but ...
(Date:2/24/2017)... 24, 2017  Xynomic Pharmaceuticals, Inc., an oncology drug ... has acquired exclusive worldwide rights to develop, manufacture ... inhibitor targeting hematological and solid tumors. ... and 2 clinical trials of Abexinostat in US, ... already been completed, demonstrating that Abexinostat is clinically ...
Breaking Medicine Technology: